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Abstract 
Background: Several epidemiologic studies indicate that maternal gestational weight gain (GWG) influences health 
outcomes in offspring. Any underlying mechanisms have, however, not been established. A recent study of 88 
children based on the Avon Longitudinal Study of Parents and Children (ALSPAC) cohort examined the methylation 
levels at 1,505 Cytosine-Guanine methylation (CpG) loci and found several to be significantly associated with maternal 
weight gain between weeks 0 and 18 of gestation. Since these results could not be replicated we wanted to examine 
associations between 0 and 18 week GWG and genome-wide methylation levels using the Infinium HumanMethyla-
tion450 BeadChip (450K) platform on a larger sample size, i.e. 729 newborns sampled from the Norwegian Mother 
and Child Cohort Study (MoBa).
Results: We found no CpG loci associated with 0–18 week GWG after adjusting for the set of covariates used in the 
ALSPAC study (i.e. child’s sex and maternal age) and for multiple testing (q > 0.9, both 1,505 and 473,731 tests). Hence, 
none of the CpG loci linked with the genes found significantly associated with 0–18 week GWG in the ALSPAC study 
were significant in our study.
Conclusions: The inconsistency in the results with the ALSPAC study with regards to the 0–18 week GWG model may 
arise for several reasons: sampling from different populations, dissimilar methylome coverage, sample size and/or false 
positive findings.
© 2015 Bohlin et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Recent genome-wide DNA methylation mapping tech-
nologies have resulted in an increasing number of stud-
ies examining epigenetic effects on offspring from 
various maternal exposures during pregnancy. For 
instance, results from the Norwegian Mother and Child 
Cohort Study (MoBa) indicate that maternal smok-
ing during pregnancy influences methylation patterns 
in the offspring [1]. Furthermore, findings from MoBa 
show an association between patterns of methylation in 
the offspring and birth weight [2]. Although maternal 
gestational weight gain (GWG) has been associated with 
offspring’s health and development during childhood [3, 
4] limited knowledge is currently available regarding epi-
genetic effects on offspring from maternal GWG.
Morales et al. conducted an epigenetic inquiry of puta-
tive effects from maternal pre-pregnancy BMI and GWG 
in cord blood DNA of 88 newborns by using data from 
the Avon Longitudinal Study of Parents and Children 
(ALSPAC) cohort [5]. They examined 807 candidate 
genes (1,505 CpG probes) for cancer using the Illumina 
GoldenGate Genotyping Assay. Several time intervals for 
GWG in pregnancy were tested, and a significant asso-
ciation between weeks 0–18 GWG, and a set of CpG 
probes linked to the genes: MMP7, KCNK4, TRPM5 and 
NFKB1 were reported. Morales et al. did not succeed in 
replicating their results in 170 non-overlapping ALSPAC 
subjects and encouraged more research based on larger 
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studies and genome-wide DNA methylation data [5]. 
Hence, the aim of the present work was to explore the 
findings from Morales et  al. using genome-wide DNA 
methylation data as well as determine the presence of any 
novel associations between newborn methylome CpG 
loci and maternal 0–18  week GWG. DNA methylation 
was measured in cord blood using the Infinium Human-
Methylation450 BeadChip (450K), from 729 newborns 
participating in the MoBa cohort.
Findings
GWG models as described in the ALSPAC study
Morales et  al. found a statistically significant associa-
tion with probes linked to the genes MMP7, KCNK4, 
TRPM5 and NFKB1 for the model describing 0–18 week 
GWG. They tested the following covariates: child’s sex, 
ethnic background, mode of delivery, maternal age, par-
ity, maternal smoking in pregnancy and occupation, 
but found only maternal age and offspring sex to be of 
importance with respect to the results. We ran a simi-
lar genome-wide model for the 473,731 probes on the 
Infinium HumanMethylation450 BeadChip (sex chro-
mosomes excluded) that overlapped with the genes rep-
resented on the Illumina GoldenGate Genotyping Assay 
examined by Morales et al. [5]. We adjusted for child’s sex 
and maternal age in accordance with the model presented 
by Morales et al. A full model containing the covariates 
child’s sex, mode of delivery, maternal age, parity, mater-
nal education and maternal daily smoking during preg-
nancy (ethnic background was irrelevant due to a highly 
homogeneous population) was also fitted but since there 
were no differences with respect to significant findings 
(see Additional file  1; Table  1) we present the simpler 
model, in accordance with the study by Morales et  al. 
Hence, we regressed CpG loci against 0–18 week GWG 
adjusted for child’s sex and maternal age. The genomic 
inflation factor (GIF) λ [6] was used as an indicator of 
hidden confounders and for model assessment [7, 8].
Our results compared to those of the ALSPAC study
From Fig. 1 it can be seen that the GIF for our 0–18 week 
GWG model was low: λ  =  1.037, but revealed no sig-
nificant methylation differences after q value correction 
(q  >  0.9, 473,731 tests, see Table  2; Additional file  2 for 
more details) [9]. Morales et  al. did however run their 
models on the Illumina GoldenGate Genotyping Assay 
which maps  1,505 CpG sites, implying that the number 
of statistical tests corrected for is considerably smaller 
than the 473,731 tests resulting from our models. Nev-
ertheless, it can be seen from the p values in Table  2 
that correcting for multiple testing in accordance with 
the Illumina GoldenGate Genotyping Assay (1,505 
tests) has no consequence for the CpG’s associated with 
the 0–18  week GWG outcome in our dataset (q  > 0.9). 
Hence, our results indicate that none of the probes were 
statistically significant for the 0–18 week GWG model.
There were substantially more CpG loci associated with 
each gene: MMP7, KCNK4, TRPM5 and NFKB1 on the 
Illumina HumanMethylation450 BeadChip platform than 
on the Illumina GoldenGate Assay used by Morales et al. 
[5], but 5 were missing (Table 2). The five CpGs missing 
in our study were typically replaced by several CpG loci 
nearby (see Table 2; Additional file 2). The HumanMeth-
ylation450 platform contained a total of 98 CpGs, most of 
which were located in the promoter region of the genes: 
MMP7, KCNK4, TRPM5 and NFKB1, and a strong asso-
ciation has been established between the HumanMethyl-
ation450 BeadChip and the GoldenGate Assay, of which 
the former is a more recent evolution rooted in the lat-
ter’s technology [10]. It has also been argued that regions 
spanning several CpGs tend to be differentially methyl-
ated as opposed to individual nucleotides therefore we 
would anticipate several proximate CpG’s to be associ-
ated with specific genes [11].
Quantifying biases that affect the methylome
One factor known to influence DNA methylation is gen-
der, and this has also been observed in the autosomes 
[12]. Including child’s sex as the only covariate in our 
0–18  weeks GWG model did not result in any notable 
differences, although the GIF decreased from λ = 1.074 
for the crude model without covariates, to λ  =  1.059. 
Several studies have indicated that cell types, especially 
those found in cord blood, may substantially influ-
ence the methylome as well [13, 14]. In our study we 
found that controlling for cell type proportions, using a 
method described by Houseman et al. [14], improved the 
Table 1 Summary statistics for  the covariates used in  the 
0–18 weeks GWG regression models, n = 729
Covariate Estimate
Child’s sex, male 48.8%
Mean age of mother at birth (years) 30.1 (95% CI 29.8–30.4)
Mean 0–18 weeks GWG (kg/week) 0.16 (95% CI 0.14–0.17)
 Not completed high-school 7.1%
 Completed high school 33.6%
 College/university 41.8%
 College/university more than 4 years 17.1%
Maternal daily smoking, yes (8 missing) 12.5%
Caesarian section, yes 6%
 1st 40.7%
 2nd 39.5%
 3rd 14.1%
 4th or more 5.6%
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model marginally with respect to GIF (λ = 0.998) com-
pared with a crude model (λ = 1.074). However, includ-
ing cell-type proportions did not lead to any differences 
with respect to significant CpG loci in any of the models 
tested, including the full model discussed above of which 
the GIF increased from λ = 1.042 to λ = 1.206. Another 
issue that may bias or influence results is the quality-
control performed on the methylome dataset. It has been 
shown that different filtering procedures could influence 
p values if the signal is weak in potential findings [15].
Strengths and weaknesses of the present study
Our study strengths include a larger number of newborns 
than the ALSPAC study and genome-wide coverage of 
CpG loci. It can however not be concluded that there 
are no effects of GWG on the methylome since the total 
methylome in the human genome is assumed to consist 
of approximately 28 million loci [16], as compared to 
the 485,512 loci mapped by the HumanMethylation450 
platform. Moreover, the mean weight gain approxi-
mately 18  weeks after conception (kg/week) for the 
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Fig. 1 GWG, between weeks 0 and 18. a Shows a qq-plot and the genomic inflation factor (λ) for the p values of 0–18 weeks GWG. The p values 
were taken from a model that was adjusted for child’s sex and maternal age. b Is the corresponding Manhattan-plot.
Table 2 Results for 0–18 weeks GWG adjusted for maternal age and child’s sex
The table shows coefficient estimates (Coef ), standard errors (Se) and p/q value estimations for the CpG loci linked to the genes found significantly differentially 
methylated in the ALSPAC study. The p values are “raw” in the sense that they are unadjusted for multiple testing; p values Bonferroni-adjusted for multiple testing 
according to the number of CpG’s on the Illumina Humanmethylation450 platform associated with each respective gene is included in brackets. The q values were 
based on multiple test corrections performed for both the HumanMethylation450 platform [GWG q value (450K), 473,731 tests] and the Golden Gate platform [GWG 
q value (GG) 1,505 tests]. CpGs marked with * were not directly observed but flanking markers are reported which were associated within the gene body (all *-marked 
CpG’s linked to the NFKB1 and TRPM5 genes) and promoter regions (*-marked CpG linked to the MMP7 gene).
Gene (# CpG’s) GoldenGate CpG Closest CpG Coef Se GWG p value (adjusted) GWG q value (450K) GWG q value (GG)
MMP7* (7) cg10521988 cg04059146 0.00706 0.00466 0.1300039 (0.9100273) 0.9198694 0.9244006
MMP7 (7) cg20645973 cg20645973 −0.00141 0.005456 0.7955276 (~1.0) 0.9600729 0.9720421
KCNK4 (26) cg01352108 cg01352108 −0.00794 0.004879 0.1041649 (~1.0) 0.9198694 0.9244006
KCNK4 (26) cg25881850 cg25881850 −0.00386 0.004814 0.4233765 (~1.0) 0.9373223 0.9244006
TRPM5 (46) cg01581060 cg01581060 −0.00152 0.004361 0.7282958 (~1.0) 0.9568195 0.9720421
TRPM5* (46) cg03982381 cg04691795 −0.01572 0.00626 0.0122687 (0.5643602) 0.9198694 0.9244006
TRPM5* (46) cg19265431 cg10172068 −0.02234 0.012938 0.012938 (0.595148) 0.9198694 0.9244006
NFKB1* (19) cg06930505 cg00790535 −0.0176 0.007064 0.0129537 (0.2461203) 0.9198694 0.9244006
NFKB1* (19) cg24413435 cg12615753 0.00936 0.006383 0.1430112 (~1) 0.9198694 0.9244006
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mothers in our study (0.16 ± 0.17, mean ± SD) was con-
siderably less than for the mothers in the ALSPAC study 
(0.32  ±  0.17, mean  ±  SD). Statistical power was also 
limited for small effect sizes; based on a post hoc power 
calculation assuming a regression model with 0–18 week 
GWG, child’s sex, maternal age and cell-type correction 
(9 explanatory variables in total) we achieved a power of 
60% for median effect sizes (R2 =  0.0610). Small effects 
sizes (lower quartile, R2  =  0.0124) resulted in a power 
below 1% (R2 refers to the proportion of variance of the 
corresponding methylation site explained by the variance 
of the regression model).
Methods
Study population
The Norwegian Mother and Child Cohort Study (MoBa) 
is a prospective population-based pregnancy cohort 
study conducted by the Norwegian Institute of Pub-
lic Health [17, 18]. MoBa recruited pregnant women 
between 1999 and 2008, at approximately 18 weeks after 
conception and mothers could participate with more 
than one pregnancy, resulting in 95,200 mothers and 
114,500 children in total. The participation rate of invited 
pregnant women was 40.6%. Umbilical cord blood sam-
ples were collected at delivery and sent by post to the 
biobank at the Norwegian Institute of Public Health 
where DNA was extracted and stored at −20°C until 
analysis [19]. The dataset used in the present study is a 
subset of the one described by Joubert et  al. [1]. From 
that dataset a sub-sample was extracted consisting of a 
random sample of children (729 in total), included in the 
analyses by Joubert et al., but children sampled because 
they had asthma at 3 years were excluded.
The MoBa cohort was linked to the Medical Birth 
Registry of Norway for information on sex of the child 
and maternal age. We used information from question-
naires completed by MoBa participants around week 18 
of their pregnancies to calculate maternal pre-pregnancy 
weight (kg), and GWG (kg/week) based on the differ-
ence between the mother’s self-reported pre-pregnancy 
weight and current weight at 18 gestational weeks.
The MoBa study has been approved by the Regional 
Committee for Medical and Health Research Ethics, the 
Norwegian Data Inspectorate and the Institution Review 
Board of the National Institute of Environment Health 
Sciences, USA. Written informed consent was provided 
by all participants.
DNA methylation technology
Cord blood DNA methylation was measured using 
the Illumina Infinium HumanMethylation450 Bead-
Chip (450K) (http://www.illumina.com). This assay was 
designed to conduct epigenome-wide association stud-
ies (EWAS), and includes 485,577 methylation (CpG) loci 
per sample at single-nucleotide resolution. This chip cov-
ers 99% of RefSeq genes, an average of 17 CpG sites per 
gene region across the promoter, 5′UTR, first exon, gene 
body, and 3′UTR. Further, the chip covers 96% of CpG 
islands, with additional coverage of island shores. Details 
regarding quality control can be found in the study by 
Joubert et al. [1] and is also outlined in Additional file 3.
Statistical analysis
The statistical analyses were performed using standard 
ordinary least squares regression on each autosomal CpG 
locus, effectually resulting in 473,731 regression models 
with 0–18 weeks GWG as the explanatory variable.
The genomic inflation factor (GIF) λ [6] for these mod-
els was calculated using the “regression”-based method 
(default) in the GenABEL package [20].
We used Bonferroni correction and q values to cor-
rect for multiple testing [9]. Covariates included in the 
adjusted model were child’s sex and maternal age (con-
tinuous). In addition, we estimated cell type proportions 
(i.e. CD4, CD8, Gran, NK, Bcell, Mono) using a method 
suggested by Houseman et  al. [14] as implemented in 
the minfi package [21]. These estimates were then added 
to the regression model described above as separate 
covariates. Several other covariates were also tested, and 
Additional file  1 contains qq-/Manhattan plots of the p 
values from a model containing the covariates: child’s sex, 
maternal age, maternal education, maternal daily smok-
ing during pregnancy, caesarian section and parity, (see 
Table 1 for summary information regarding these covari-
ates) however no differences were detected and therefore 
the simple model proposed by Morales et al. [5] was pre-
sented as the main model.
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